Jpmorgan Chase & CO Pacific Biosciences Of California, Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PACB
# of Institutions
251Shares Held
231MCall Options Held
971KPut Options Held
965K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.4MShares$85.2 Million0.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA26MShares$66.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$60.2 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$59.6 Million5.63% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V816.7MShares$42.7 Million0.4% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $573M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...